Next Article in Journal
Post-Mortem Detection of SARS-CoV-2 RNA in Long-Buried Lung Samples
Next Article in Special Issue
Late Changes in the Extracellular Matrix of the Bladder after Radiation Therapy for Pelvic Tumors
Previous Article in Journal
Method for Diagnosing the Bone Marrow Edema of Sacroiliac Joint in Patients with Axial Spondyloarthritis Using Magnetic Resonance Image Analysis Based on Deep Learning
Previous Article in Special Issue
Prospects of Intraoperative Multimodal OCT Application in Patients with Acute Mesenteric Ischemia
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Microperimetry-Assessed Functional Alterations and OCT-Changes in Patients after Retinal Detachment Surgery Using Pars Plana Vitrectomy and SF6 Tamponade

by
María D. Díaz-Barreda
1,2,3,
Isabel Bartolomé-Sesé
1,2,3,
Ana Boned-Murillo
1,2,3,
Antonio Ferreras
2,3,4,
Elvira Orduna-Hospital
2,5,
Francisco J. Ascaso
1,2,3 and
Isabel Pinilla
1,2,3,*
1
Department of Ophthalmology, Lozano Blesa University Hospital, 50009 Zaragoza, Spain
2
Aragón Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain
3
Department of Surgery, School of Medicine, University of Zaragoza, 50009 Zaragoza, Spain
4
Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain
5
Department of Applied Physics, University of Zaragoza, 50009 Zaragoza, Spain
*
Author to whom correspondence should be addressed.
Diagnostics 2021, 11(7), 1157; https://doi.org/10.3390/diagnostics11071157
Submission received: 18 May 2021 / Revised: 11 June 2021 / Accepted: 21 June 2021 / Published: 24 June 2021

Abstract

:
Background: We study the retinal function measured by macular integrity assessment microperimetry (MAIA) and structural changes assessed by scanning swept source optical coherence tomography (SS-OCT) between healthy individuals and patients undergoing pars plana vitrectomy (PPV) after rhegmatogenous retinal detachment (RRD). Methods: Cross-sectional study. Early Treatment Diabetic Retinopathy Study (ETDRS) grids were measured by SS-OCT and compared with the MAIA parameters. Results: Thirty-eight eyes with RRD (19 macula-on and 19 macula-off) were compared with 113 healthy eyes. The retinal sensitivity and average total threshold were reduced in all sectors in the RRD group; macular integrity index was increased. Macular thicknesses in total retina and ganglion cell layer (GCL)++ protocols were higher in the RRD group in nasal outer (NO) and central (C) sectors and only in C sector for GCL+ protocol. Thicknesses were lower in total retina, GCL++ protocols in the temporal outer (TO) sector and in the GCL+ protocol in NO sector. Best-corrected visual acuity (BCVA) correlated moderately with retinal sensitivity in all sectors and in just several sectors with time between the date of surgery and the test. The central nasal (CN) sector thickness and the average total threshold were higher in the macula-on subgroup. Conclusions: RRD and subsequent surgery results in functional and structural changes, especially in individuals with macular detachment.

1. Introduction

Rhegmatogenous retinal detachment (RRD) is the most common type of retinal detachment with an incidence between 9.5 and 18.2 cases per 100,000 inhabitants per year [1]. Pars plana vitrectomy (PPV) along the gas tamponade achieves high anatomical success [2]. Despite great advances in RRD surgery with anatomic reattachment close to 100%, functional improvement is not always as expected since it comes with possible visual acuity (VA) loss, contrast sensitivity, color vision alterations or metamorphoses. These changes negatively affect the quality of life due to visual impairment [3,4,5]. RRD recovery behaves differently according to whether or not the macula is involved; the impairment the fovea and the central 10 degrees of the retina could cause a significant detriment to the patient’s quality of life [6]. The importance of macular involvement is not well-known for the end retinal sensitivity result [7]. Presurgical variables, such as previous best-corrected VA (BCVA); time between the onset of symptoms and surgery; extension of the RRD; macular involvement before surgery; vitreomacular traction and distance between the outer limiting membrane and photoreceptors outer segments measured by optical coherence tomography (OCT) may affect the final best-corrected visual acuity (BCVA) and other functional parameters [4,5,8]. Postsurgical variables, such as cystoid macular edema or retinal folds; epiretinal membrane formation; retinal pigment epithelium (RPE) migration; rupture and loss of the photoreceptors; and persistence of subretinal fluid may also affect the final vision [3,9]. Histological modifications after RDD have been studied in animal models and they have proven that in the first 24 h after RRD, RPE changes are already occurring [10]. After 24 h to 72 h, photoreceptor outer segments begin to degenerate and retinal changes progress over time with inner segment degeneration [11], changes in the outer nuclear layer and outer plexiform layer and neuronal remodeling [12,13]. The correct juxtaposition of the RPE and neurosensorial retina can stop the process, although it is not clear whether this can achieve involution and recovery, either partial or complete, of the affected cells. [14]
The introduction of OCT has allowed us to study microstructural changes in the retinal layers [15,16].
Tests to assess retinal function have also improved remarkably. Macular function can be studied using either psychophysiological or electrophysiological test. Psychophysical tests include VA, color vision, Amsler grid, photostress and microperimetry among others. They offer different characteristics of macular function including minimum angular separation, color perception, defect in the central field, photoreceptor recovery with respect to bright lights or central retinal sensitivity [17]. In recent years, the macular integrity assessment (MAIA) microperimetry was introduced to clinical practice. MAIA provides several improvements over conventional and kinetic perimetry [18,19,20], such as the possibility of seeing the retina in real-time while performing the test [21], analysis of retinal sensitivity and the ability to analyze fixation with the “eye tracker” system [19,22].
The aim of the present study was to evaluate and compare the retinal thickness changes measured by swept source optical coherence tomography (SS-OCT) and the functional parameters obtained with MAIA microperimetry between eyes that underwent RRD surgery depending on the previous macula status and healthy eyes.

2. Materials and Methods

The study protocol adhered to the tenets of the Helsinki Declaration. The study complied with Spanish legislation in the field of biomedical research; in the protection of personal data, Organic Law 3/2018 on the Protection of Personal Data; Basic Law 41/2002, regulating patient autonomy and rights; obligations regarding information and clinical documentation; and Law 14/2007 on biomedical research. The study was approved by the Aragon Clinical Research Committee with ID PI19/253.
We conducted a unicentric cross-sectional study at the Ophthalmology Department of the Hospital Clínico Universitario Lozano Blesa, Zaragoza, from October 2018 to October 2019. Patients who had undergone RRD surgery were included in the study. They were asked to attend regular check-ups at the Ophthalmology Department during the follow-up and they agreed to take part in the study by signing the Informed Consent form. A total of 38 patients possessing primary RRD with fewer than 2 weeks between the onset of symptoms and surgery and the absence of other ocular pathologies that could compromise the BCVA with successful surgical reattachment after 23G PPV plus sulfur-hexafluoride (SF6) tamponade were included. Nineteen of the subjects were macula On RRD and 19 had macular involvement (macula Off). The time elapsed between surgery and study testing ranged from 15 days to 4 years. All the tests were performed with a complete disappearance of the intraocular SF6. The post-surgical BCVA had to be below 1.0 (logMAR scale). Exclusion criteria included proliferative vitreoretinopathy above grade B; ocular pathology affecting central vision (age-related macular degeneration, pathological myopia, macular hole, epiretinal membrane, diabetic retinopathy with clinically significant macular oedema, glaucoma diagnosed with perimetric involvement, papillary atrophy, amblyopia and macular scarring); intraocular pressure (IOP) over 20 mmHg; and the lack of fixation or cooperation during the exam.
Control group included family members or healthcare personnel with no previous history of eye disease. All of them signed the Informed Consent form.
All participants underwent a comprehensive ophthalmologic evaluation, including date of birth, sex, ophthalmologic history, refractometry, axial length (AL) and spherical equivalent (SE) measured with the ALADDIN KR-1W Series optical biometry system (Topcon Corporation, Tokyo, Japan), BCVA (measured according to the logMAR scale), intraocular pressure with a Goldmann applanation tonometer, macular status (on/off) and checking for the absence of vitreoretinal proliferation of any grade.
Macular retinal sensitivity was evaluated by MAIA (MAIA, Macular Integrity Assessment system, CenterVue SpA, Padova, Italy) carrying out an Expert Exam following 4-2 strategy. It provides an analysis of 37 retinal sensitivity points corresponding to specific stimulated locations represented by a color scale map. It also reports data on fixation losses (percentage), macular integrity index, average total threshold, fixation stability, bivariate contour ellipse area (BCEA) and BCEA 63% and 95% angles were measured. The macular integrity index corresponds to a numerical value ranging from 0 to 100 indicating whether a patient’s response is normal (close to 0), suspicious or abnormal (as it approaches to 100). Depending on the number of measured fixation points within a circle having radius of 2° (p1) or 4° (p2), fixation stability was considered stable (p1 and p2 > 75%), relatively unstable (p1 < 75% and p2 > 75%) or unstable (p1 and p2 < 75%). BCEA corresponds to the area of 2 ellipses perpendicular to one another containing 63% (minor ellipse) or 95% (major ellipse) of the fixation points, respectively. The angle between them indicates the direction in which the eye movements are oriented during the test. These data are shown in Figure 1.
After dilating the pupil with tropicamide eye drops (Tropicamida®, Alcon Cusi, Barcelona, Spain) a fundus examination and macular SS-OCT (Deep Range Imaging (DRI)-Triton SS-OCT, (Topcon Corporation, Tokyo, Japan) were performed. A macular 6.0 × 6.0 mm three-dimensional scan was obtained and the automatic segmentation of each retinal layer was performed by the IMAGEnet 6 software Version 1.22.1.14101© 2014 (Topcon Corporation, Tokyo, Japan). The total retinal thickness, the GCL+ (ganglion cell layer (GCL) plus inner plexiform layer (IPL)) thickness and ganglion cell complex (GCC; GCL++ comprising GCL+ plus retinal nerve fiber layer (RNFL)) thickness were measured.
In order to correlate the data provided by MAIA and SS-OCT, we divided the 37 points provided by microperimetry into sectors similar to those automatically generated by OCT following the Early Treatment Diabetic Retinopathy Study (ETDRS) grid. Assuming that for emmetropic eyes, a degree would be approximately equivalent to a radius of 0.3 mm, 3° to 0.9 mm and 5° to 1.5 mm [23,24]. In this manner, the central point and the 12 points of the first concentric circle would correspond to the central sector (C) of the OCT. This is reflected in Figure 2.
In the MAIA parameters, we differentiated the central point, referred to as C, and the 12 surrounding points in the 4 quadrants. We referred to these 12 points with the letter C as the central sector, followed by the letter S for the superior sector, T for temporal, I for inferior and N for nasal. In addition, we averaged the 13 points included in the central sectors and we termed the value C global. The thresholds of the radius of 3° (inner (I)) and 5° (outer (O)) of the MAIA would correspond to the inner ring or parafovea of the OCT. We subdivided them into 4 quadrants (S, T, I, N). To obtain a figure that allows us to compare the results of each with the other and we averaged the sensitivity threshold of the points included in each sector. The microperimetry fundoscopic images were exported from the MAIA and incorporated into the SS-OCT for later analysis and comparison.
Elapsed time from the date of surgery to the date when the structural and functional tests were performed was also recorded.

Statistical Analysis

Statistical analysis was performed using SPSS (SPSS 25, SPSS Inc., IBM Corporation, Somers, NY, USA). Variables are expressed as mean, standard deviation and median and range when the variable was non-parametric. Qualitative variables are expressed as number of cases and as percentages. Normality was analyzed with the Kolmogorov Smirnov’s test. Since most of the parameters were not normal, non-parametric tests were performed. Differences between groups were analyzed with the Mann–Whitney U test for independent samples. The Spearman correlation test was used for the bivariate analysis in the comparison of the structural and functional outcomes. In all analyses, we considered p < 0.05 to indicate statistical significance.

3. Results

3.1. Subsection Comparison of Control Group vs. RRD Group

A total of 151 eyes were analyzed, including 38 RRD eyes and 113 controls. The control group comprised of 55 women (48.7%) and 58 men (51.3%); and 59 right eyes (52.2%) and 54 left eyes (47.8%). The RRD group comprised of 12 women (31.6%) and 26 men (68.4%); and 17 right eyes (44.7%) and 21 left eyes (55.3%). The mean age of the control group was 58.48 ± 9.65 years (33–83) and the mean age of the RRD group was 58.29 ± 9.02 years (22–72; p = 0.603). Intraocular pressure was also similar in both groups (control group: 13.59 ± 2.64 and RRD group: 14.42 ± 2.26 mmHg). No differences in sex, laterality, age or intraocular pressure were found between groups.
BCVA was higher in the control group (0.05 ± 0.08 logMAR) than in the RRD group (0.16 ± 0.18 logMAR; p < 0.001). The SE was lower in the RRD group, while AL was lower in the control group.
The macular integrity index was lower in the control group (p < 0.001), while the average total threshold was higher (p < 0.001), which indicates a higher probability of finding normal values in terms of sensitivity in the control group. No differences in the fixation stability or BCEA parameters were detected between groups (Table 1).
Retinal sensitivity determined by MAIA was lower in all sectors in the RDD group as can be seen in Figure 3. It shows the macular sensitivity values provided by the MAIA which are grouped in the sensitivity map according to the color scale.
In the total retina protocol, an increase in the retinal thickness was observed in the nasal outer (NO) (p = 0.001) and the central (C) (p = 0.040) sectors in the RRD group compared with the control group while the temporal outer (TO) sector was decreased (p = 0.010). Using the GCL+ protocol, the retinal thickness was higher in the C sector (p = 0.001) and lower in the NO sector (p = 0.048) in the RRD group. In the GCL++ protocol retinal thickness increased in the NO (p = 0.001) and the C (p = 0.002) sectors and diminished in the TO (p = 0.002) in the RRD group (Figure 4).
No correlation was detected between the C global sector evaluated by MAIA and ETDRS C thickness measured with the SS-OCT, regardless of the protocol used.
The ETDRS sector inferior inner (II) of the GCL+ protocol correlated with the TO (r = 0.197; p = 0.015), inferior outer (IO) (r = 0.187; p = 0.022), NO (r = 0.199; p = 0.014), superior inner (SI) (r = 0.170; p = 0.037), temporal inner (TI) (r = 0.162; p = 0.047), II (r = 0.191; p = 0.019) and nasal inner (NI) (r = 0.191; p = 0.019) sectors of the MAIA (Table 2).
Additionally, the ETDRS nasal inner (NI) sector of the GCL+ protocol correlated with the TO sector (r = 0.180; p = 0.027) of the MAIA.
The macular integrity index and average total threshold of MAIA microperimetry were mildly to moderately correlated with age, BCVA and spherical equivalent (Table 3).
BCVA (logMAR) yielded moderate negative correlations with retinal sensitivity determined by MAIA at all sectors.

3.2. Comparison between the Macula-On and Macula-Off Subgroups

The macula-on subgroup included 26.32% women and 73.68% men, while the macula-off subgroup comprised 36.84% women and 63.16% men (p = 0.485). Retinal sensitivity measured by MAIA in the central nasal sector and the average total threshold were lower in the RRD subgroup with macula-off (Table 4 and Figure 5).
Total retinal, GCL+ and GCL++ thicknesses were similar between the subgroups as can be observed in Figure 6.
The number of days that elapsed between the surgery and test date correlated moderately with the logMAR BCVA (r = −0.463; p = 0.003) and retinal sensitivity evaluated by MAIA in the superior outer (r = 0.340; p = 0.037), temporal inner (r = 0.342; p = 0.035), C (r = 0.385; p = 0.017), central temporal (r = 0.372; p = 0.022) sectors and C global (r = 0.417; p = 0.009).

4. Discussion

In our study, macular sensitivity was affected by RRD and related surgical procedures. We studied a consecutive series of RRD treated with 23G PPV, endophotocoagulation and 25% SF6 as tamponade. Retinal sensitivity was reduced in all sectors measured by MAIA in the group of patients undergoing surgery for RRD compared with healthy subjects. Based on anatomic changes measured by structural SS-OCT, the differences were less marked and occurred only in the horizontal areas of the perifoveal ring and in the central area (TO, NO and C).
The inferior inner sector of the GCL+ protocol, including the GCL–IPL complex, showed mild correlations with all the sectors of the MAIA except the superior outer sector. The nasal inner sector of the GCL+ also correlated with the TO sector of the MAIA. These changes at the inner retinal layers could be explained by the damage caused by the RRD itself, especially in retinal detachments with macular involvement as well as some of the surgical maneuvers: modifications of the intraocular pressure, use of perfluorocarbon liquid, fluid–air exchange or gas injection. Alterations in the outer retina, such as the loss of the photoreceptor outer and inner segments, and photoreceptor cell body or outer plexiform layer changes have been described in animal models or after retinal detachment surgery that may correlate with the visual function. The disconnection between the outer nuclear layer and the RPE generates these first changes [10,11]. Nevertheless, we were unable to find any OCT change at the outer retinal layers depending on the pre-surgical macular status [25], which could be related to the number of studied patients or to the short surgery delay. Only a few studies, however, have focused on inner retina modifications after RRD surgery. Changes in postsynaptic neurons are a common finding in nervous system lesions. Ganglion cell downregulation has been described in an experimental model of retinal detachment and another study observed RNFL thinning over time [26,27]. In our study, we found alterations in the inner retinal layers in patients that underwent RRD surgery and they are predominantly in the GCC or total retinal thickness with fewer effects in the GCL–IPL complex.
In all studied protocols, GLC+, GCL++ and total retinal thickness were slightly different between both macula-on and macula-off RRD subgroups and between the RRD group and control group; however, the differences were more evident when the RNFL was included in the thickness measurement. We found an increase in retinal thickness in the central and NO areas of RRD group. The activation of the Müller cell after the RRD and the presence of subtle epiretinal membrane or subretinal fluid pockets could justify this increase. It seems that the damage produced after RRD is mainly axonal without a clear loss of ganglion cell bodies. Previous studies described the sequence and mechanisms that results in the loss of the GCL in other diseases such as glaucoma or diabetes [28,29,30].
Montesano et al. [16] reported difficulties in determining whether a particular functional area correlates with ganglion cells located immediately below or spatially distant based on the histologic studies of Drasdo el al. [31]. We did not consider displacement of the ganglion cells from their fields due to the already described variability between subjects. For this reason, we correlated the MAIA and OCT points in their exact locations.
The anatomic and functional changes that occur in the retina after surgery for RRD repair have rarely been evaluated with both OCT and microperimetry. Smith et al. [4] studied a sample of 17 RRD macula-off after surgeries using time-domain OCT (Stratus) and spectral-domain OCT. Of the 17 cases, 11 were functionally evaluated using MP-1 microperimetry and 6 exhibited functional alterations related to different OCT findings. Lai et al. [32] compared their results obtained after performing spectral-domain OCT, autofluorescence and microperimetry (MP-1) in patients undergoing RRD surgery. They found disruption in the outer limiting membrane, photoreceptors and the photoreceptor inner segment/outer segment junction in 43.2% of the cases, while 56.8% presented with blue autofluorescence anomalies related to the OCT findings. The areas of structural, microvascular and functional alterations were similar in both groups and associated with worse BCVA. Scheerlinck et al. [33] studied 40 PPV for RRD by OCT and microperimetry (OptosOCT/confocal scanning laser ophthalmoscopy (SLO)) at 1 and 2 months after surgery. Half of them underwent surgery using SF6 as tamponade and the other half with a worse prognosis underwent surgery with silicone oil tamponade. They found better BCVA and fewer OCT changes in individuals in which SF6 was used. Although there was evidence of GCL and IPL thinning and a possible influence on fovea homeostasis due to their contact with the silicon oil, the patients were not randomized and thus the silicon oil was used in patients with a negative prognosis factor, which may have biased the results. Noda et al. [34] compared pre-surgical and post-surgical (6 months after surgery) MAIA and SS-OCT data in 34 macula-off RRD. They found an improvement in sensitivity after surgery and concluded that postoperative ellipsoid zone continuity was important for good postoperative retinal sensitivity. Borowicz et al. [7] carried out a prospective study with 62 patients after PPV with SF6 tamponade for RRD repairment, 28 with macula-on and 34 with macula-off performing OCT-2000 and MAIA assessment at 3 months and 6 months after surgery. This overcomes two of the major limitations of our study by increasing the sample size and rendering it prospective rather than cross-sectional. They obtained a final BCVA similar to ours for patients with macula-on (0.15 ± 0.20 in their study vs. 0.13 ± 0.1 in our study); however, results were not similar for the case of macula-off eyes. Their BCVA was 0.40 ± 0.28 and ours was 0.19 ± 0.17. Our exclusion criteria included post-surgical vision below 1.0 (logMAR scale) and any factor that could affect central vision because we considered that low VA must affect the MAIA test results and thus rendering the test unreliable. The number of days that elapsed between surgery and the date of the functional and imaging tests was negatively correlated with the BCVA (logMAR), suggesting an improvement in the patient’s visual function. Moreover, the elapsed time showed a positive correlation with different MAIA sectors. This finding suggests that BCVA could improve over time and that functional improvement requires a longer follow-up to be detected than that proposed by Borowicz. They reported no differences related to the elapsed time between the intervention and the testing procedure, except for the P1 value (p = 0.02) obtained by MAIA which improved during the follow-up. This could be related to either the structural and functional recovery of the retina or to a learning effect after performing the test more than once. Another reason could be the development derived from the plasticity of the visual system [21,35]. Several studies on patients with different macular pathologies have used devices such as the MP-1 microperimeter (which offers different biofeedback strategies) or even video game stimulation to define a new preferred retinal locus (PRL), which would act as a pseudofovea and optimize residual vision and enhance the fixation. They concluded that flexibility in the ocular motor system exists and could improve the fixation although it does not necessarily have to be accompanied by increased retinal sensitivity [35,36,37]. This could be in favor of an improvement in fixation stability and visual outcomes over time.
We did not find significant differences regarding fixation capacity and stability was not found between the control group and the DRR group nor between the macula-on and macula-off subgroups. Due to the lack of follow-ups, one of the main limitations of our study is that we cannot confirm changes in the fixation data.
In conclusion, RRD and the surgery performed to repair RRD results in functional and structural changes, including alterations in the inner retinal layer and especially in individuals with macular involvement. These changes can be functionally quantified by MAIA and anatomically assessed by SS-OCT. Findings obtained using both techniques correlate with each other. Our findings help to clarify the implications of surgical intervention after RRD and its effect on the patient’s BCVA. Future prospective studies with larger sample sizes would help to strengthen these results.

Author Contributions

Conceptualization, M.D.D.-B., A.B.-M., E.O.-H. and I.P.; methodology, M.D.D.-B., A.B.-M. and I.P.; formal analysis, M.D.D.-B. and A.F.; investigation, M.D.D.-B., I.B.-S., A.B.-M. and I.P.; writing—original draft preparation, M.D.D.-B., A.B.-M., I.B.-S. and I.P.; writing—review and editing, M.D.D.-B. and I.P.; funding acquisition, F.J.A. and I.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Aragon Clinical Research Committee with ID PI19/253, 5 June 2019.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bechrakis, N.E.; Dimmer, A. Rhegmatogene Netzhautablosung: Epidemiologie und Risikofaktoren. Ophthalmologe 2018, 115, 163–178. [Google Scholar] [CrossRef] [Green Version]
  2. Liao, L.; Zhu, X.H. Advances in the treatment of rhegmatogenous retinal detachment. Int. J. Ophthalmol. 2019, 12, 660–667. [Google Scholar] [CrossRef] [PubMed]
  3. Okuda, T.; Higashide, T.; Sugiyama, K. Metamorphopsia and outer retinal morphologic changes after successful VITRECTOMY surgery for macula-off rhegmatogenous retinal detachment. Retina 2018, 38, 148–154. [Google Scholar] [CrossRef]
  4. Smith, A.J.; Telander, D.G.; Zawadzki, R.J.; Choi, S.S.; Morse, L.S.; Werner, J.S.; Park, S.S. High-resolution Fourier-domain optical coherence tomography and microperimetric findings after macula-off retinal detachment repair. Ophthalmology 2008, 115, 1923–1929. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Gupta, R.R.; Iaboni, D.S.M.; Seamone, M.E.; Sarraf, D. Inner, outer, and full-thickness retinal folds after rhegmatogenous retinal detachment repair: A review. Surv. Ophthalmol. 2019, 64, 135–161. [Google Scholar] [CrossRef]
  6. Smretschnig, E.; Falkner-Radler, C.I.; Binder, S.; Sporl, J.; Ristl, R.; Glittenberg, C.; Krepler, K. Vision-Related Quality of Life and Visual Function after Retinal Detachment Surgery. Retina 2016, 36, 967–973. [Google Scholar] [CrossRef]
  7. Borowicz, D.; Nowomiejska, K.; Nowakowska, D.; Brzozowska, A.; Toro, M.D.; Avitabile, T.; Junemann, A.G.; Rejdak, R. Functional and morphological results of treatment of macula-on and macula-off rhegmatogenous retinal detachment with pars plana vitrectomy and sulfur hexafluoride gas tamponade. BMC Ophthalmol. 2019, 19, 118. [Google Scholar] [CrossRef]
  8. Hirata, N.; Iwase, T.; Kobayashi, M.; Yamamoto, K.; Ra, E.; Terasaki, H. Correlation between preoperative factors and final visual acuity after successful rhegmatogenous retinal reattachment. Sci. Rep. 2019, 9, 3217. [Google Scholar] [CrossRef] [Green Version]
  9. Karacorlu, M.; Sayman Muslubas, I.; Hocaoglu, M.; Arf, S.; Ersoz, M.G. Correlation between morphological changes and functional outcomes of recent-onset macula-off rhegmatogenous retinal detachment: Prognostic factors in rhegmatogenous retinal detachment. Int. Ophthalmol. 2018, 38, 1275–1283. [Google Scholar] [CrossRef]
  10. Fisher, S.K.; Lewis, G.P.; Linberg, K.A.; Verardo, M.R. Cellular remodeling in mammalian retina: Results from studies of experimental retinal detachment. Prog. Retin. Eye Res. 2005, 24, 395–431. [Google Scholar] [CrossRef] [PubMed]
  11. Linberg, K.A.; Lewis, G.P.; Fisher, S.K. Retraction and remodeling of rod spherules are early events following experimental retinal detachment: An ultrastructural study using serial sections. Mol. Vis. 2009, 15, 10–25. [Google Scholar] [PubMed]
  12. Cook, B.; Lewis, G.P.; Fisher, S.K.; Adler, R. Apoptotic photoreceptor degeneration in experimental retinal detachment. Investig. Ophthalmol. Vis. Sci. 1995, 36, 990–996. [Google Scholar]
  13. Wilson, D.J.; Green, W.R. Histopathologic study of the effect of retinal detachment surgery on 49 eyes obtained post mortem. Am. J. Ophthalmol. 1987, 103, 167–179. [Google Scholar] [CrossRef]
  14. Wilkinson, C.; Hinton, D.; Sada, S.; Wiedemann, P. Ryan Retina. In Retina, 6th ed.; Elsevier: Amsterdam, The Netherlands, 2017; Volume 3. [Google Scholar]
  15. Blumenthal, E.Z.; Williams, J.M.; Weinreb, R.N.; Girkin, C.A.; Berry, C.C.; Zangwill, L.M. Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. Ophthalmology 2000, 107, 2278–2282. [Google Scholar] [CrossRef]
  16. Wolf, S.; Wolf-Schnurrbusch, U. Spectral-domain optical coherence tomography use in macular diseases: A review. Ophthalmologica 2010, 224, 333–340. [Google Scholar] [CrossRef]
  17. Laishram, M.; Srikanth, K.; Rajalakshmi, A.R.; Nagarajan, S.; Ezhumalai, G. Microperimetry—A New Tool for Assessing Retinal Sensitivity in Macular Diseases. J. Clin. Diagn. Res. 2017, 11, Nc08–Nc11. [Google Scholar] [CrossRef] [PubMed]
  18. Molina-Martin, A.; Pinero, D.P.; Perez-Cambrodi, R.J. Normal values for microperimetry with the MAIA microperimeter: Sensitivity and fixation analysis in healthy adults and children. Eur. J. Ophthalmol. 2017, 27, 607–613. [Google Scholar] [CrossRef]
  19. Molina-Martin, A.; Perez-Cambrodi, R.J.; Pinero, D.P. Current Clinical Application of Microperimetry: A Review. Semin. Ophthalmol. 2018, 33, 620–628. [Google Scholar] [CrossRef] [Green Version]
  20. Hirooka, K.; Misaki, K.; Nitta, E.; Ukegawa, K.; Sato, S.; Tsujikawa, A. Comparison of Macular Integrity Assessment (MAIA), MP-3, and the Humphrey Field Analyzer in the Evaluation of the Relationship between the Structure and Function of the Macula. PLoS ONE 2016, 11. [Google Scholar] [CrossRef] [PubMed]
  21. Han, R.C.; Jolly, J.K.; Xue, K. Effects of pupil dilation on MAIA microperimetry. Clin. Exp. Ophthalmol. 2017, 45, 489–495. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Longhin, E.; Convento, E.; Pilotto, E. Static and dynamic retinal fixation stability in microperimetry. Can. J. Ophthalmol. 2013, 48, 375–380. [Google Scholar] [CrossRef]
  23. Photocoagulation for Diabetic Macular Edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch. Ophthalmol. 1985, 103, 1796–1806. [Google Scholar] [CrossRef]
  24. Montesano, G.; Gervasoni, A.; Ferri, P.; Allegrini, D.; Migliavacca, L.; De Cilla, S.; Rossetti, L. Structure-function relationship in early diabetic retinopathy: A spatial correlation analysis with OCT and microperimetry. Eye 2017, 31, 931–939. [Google Scholar] [CrossRef]
  25. Akkoyun, I.; Yilmaz, G. OCT-, anatomische und funktionelle Ergebnisse nach Plombenchirurgie bei Macula-off rhegmatogener Ablatio retinae. Klin. Monbl. Augenheilkd. 2013, 230, 814–819. [Google Scholar] [CrossRef]
  26. Coblentz, F.E.; Radeke, M.J.; Lewis, G.P.; Fisher, S.K. Evidence that ganglion cells react to retinal detachment. Exp. Eye Res. 2003, 76, 333–342. [Google Scholar] [CrossRef]
  27. Lee, Y.H.; Lee, J.E.; Shin, Y.I.; Lee, K.M.; Jo, Y.J.; Kim, J.Y. Longitudinal changes in retinal nerve fiber layer thickness after vitrectomy for rhegmatogenous retinal detachment. Investig. Ophthalmol. Vis. Sci. 2012, 53, 5471–5474. [Google Scholar] [CrossRef] [Green Version]
  28. Kanamori, A.; Nakamura, M.; Escano, M.F.; Seya, R.; Maeda, H.; Negi, A. Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. Am. J. Ophthalmol. 2003, 135, 513–520. [Google Scholar] [CrossRef]
  29. Park, H.Y.; Kim, I.T.; Park, C.K. Early diabetic changes in the nerve fibre layer at the macula detected by spectral domain optical coherence tomography. Br. J. Ophthalmol. 2011, 95, 1223–1228. [Google Scholar] [CrossRef] [PubMed]
  30. Elvira Orduna Hospital. Variaciones en el Espesor de Las Capas de la Retina y La Coroides en Diabéticos Tipo I Sin Retinopatía; Óptica y Optometría; Universidad de Zaragoza: Zaragoza, Spain, 2018. [Google Scholar]
  31. Drasdo, N.; Millican, C.L.; Katholi, C.R.; Curcio, C.A. The length of Henle fibers in the human retina and a model of ganglion receptive field density in the visual field. Vis. Res. 2007, 47, 2901–2911. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Lai, W.W.; Leung, G.Y.; Chan, C.W.; Yeung, I.Y.; Wong, D. Simultaneous spectral domain OCT and fundus autofluorescence imaging of the macula and microperimetric correspondence after successful repair of rhegmatogenous retinal detachment. Br. J. Ophthalmol. 2010, 94, 311–318. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Scheerlinck, L.M.; Schellekens, P.A.; Liem, A.T.; Wong, D.; Steijns, D.; Van Leeuwen, R. Retinal sensitivity following intraocular silicone oil and gas tamponade for rhegmatogenous retinal detachment. Acta Ophthalmol. 2018, 96, 641–647. [Google Scholar] [CrossRef] [PubMed]
  34. Noda, H.; Kimura, S.; Hosokawa, M.M.; Shiode, Y.; Doi, S.; Takahashi, K.; Matoba, R.; Kanzaki, Y.; Fujiwara, A.; Morizane, Y. Effect of rhegmatogenous retinal detachment on preoperative and postoperative retinal sensitivities. Sci. Rep. 2020, 10, 21497. [Google Scholar] [CrossRef] [PubMed]
  35. Tarita-Nistor, L.; González, E.G.; Markowitz, S.N.; Steinbach, M.J. Plasticity of fixation in patients with central vision loss. Vis. Neurosci. 2009, 26, 487–494. [Google Scholar] [CrossRef] [Green Version]
  36. Amore, F.M.; Paliotta, S.; Silvestri, V.; Piscopo, P.; Turco, S.; Reibaldi, A. Biofeedback stimulation in patients with age-related macular degeneration: Comparison between 2 different methods. Can. J. Ophthalmol. 2013, 48, 431–437. [Google Scholar] [CrossRef] [PubMed]
  37. Ratra, D.; Rakshit, A.; Ratra, V. Visual rehabilitation using video game stimulation for Stargardt disease. Ther. Adv. Ophthalmol. 2019, 11, 2515841419831158. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. (A) Modified image provided by MAIA microperimetry showing the 37 sensitivity points on a color scale map. (B) BCEA data corresponding to a patient examined during the study. The BCEA corresponds to the area of two ellipses; “a” containing 63% (minor ellipse) and “b” containing 95% (major ellipse) of the fixation points. MAIA: macular integrity assessment, BCEA: bivariate contour ellipse area.
Figure 1. (A) Modified image provided by MAIA microperimetry showing the 37 sensitivity points on a color scale map. (B) BCEA data corresponding to a patient examined during the study. The BCEA corresponds to the area of two ellipses; “a” containing 63% (minor ellipse) and “b” containing 95% (major ellipse) of the fixation points. MAIA: macular integrity assessment, BCEA: bivariate contour ellipse area.
Diagnostics 11 01157 g001
Figure 2. Images provided SS-OCT (A) and MAIA (B) of the same patient modified to represent the correlation between the two. SS-OCT: swept source optical coherence tomography, MAIA: macular integrity assessment.
Figure 2. Images provided SS-OCT (A) and MAIA (B) of the same patient modified to represent the correlation between the two. SS-OCT: swept source optical coherence tomography, MAIA: macular integrity assessment.
Diagnostics 11 01157 g002
Figure 3. Comparative results between the control group (A) and the group of patients with RRD (B) for retinal sensitivity measured by MAIA in dB in the study sectors. MAIA: macular integrity assessment; ETDRS: Early Treatment Diabetic Retinopathy Study; RRD: rhegmatogenous retinal detachment; C global: central global. Significant comparisons between the groups (p < 0.05) are presented in gray background (p < 0.05) or darker gray background (p < 0.01).
Figure 3. Comparative results between the control group (A) and the group of patients with RRD (B) for retinal sensitivity measured by MAIA in dB in the study sectors. MAIA: macular integrity assessment; ETDRS: Early Treatment Diabetic Retinopathy Study; RRD: rhegmatogenous retinal detachment; C global: central global. Significant comparisons between the groups (p < 0.05) are presented in gray background (p < 0.05) or darker gray background (p < 0.01).
Diagnostics 11 01157 g003
Figure 4. Macular parameters assessed by SS-OCT in both groups. Figures (AC) represent control group outcomes while figures (DF) represent RRD group outcomes. On top of each figure it is specified the SS-OCT protocol used. Total retinal thickness, GCL+ protocol and GCL++ protocol values are expressed in microns. Mean +/- standard deviation is included in every sector. Significant differences between the groups (p < 0.05) are presented in gray background. SS-OCT: swept source optical coherence tomography; MAIA: macular integrity assessment; ETDRS: Early Treatment Diabetic Retinopathy Study; RRD: rhegmatogenous retinal detachment; GCL: ganglion cell layer.
Figure 4. Macular parameters assessed by SS-OCT in both groups. Figures (AC) represent control group outcomes while figures (DF) represent RRD group outcomes. On top of each figure it is specified the SS-OCT protocol used. Total retinal thickness, GCL+ protocol and GCL++ protocol values are expressed in microns. Mean +/- standard deviation is included in every sector. Significant differences between the groups (p < 0.05) are presented in gray background. SS-OCT: swept source optical coherence tomography; MAIA: macular integrity assessment; ETDRS: Early Treatment Diabetic Retinopathy Study; RRD: rhegmatogenous retinal detachment; GCL: ganglion cell layer.
Diagnostics 11 01157 g004
Figure 5. Comparison for retinal sensitivity (dB) assessed by MAIA microperimetry between macula-on (A) and macula-off (B) subgroups. Mean +/− standard deviation is included in every sector. Significant differences between the groups (p < 0.05) are presented in the gray background. MAIA: macular integrity assessment. RRD: rhegmatogenous retinal detachment; C global: central global.
Figure 5. Comparison for retinal sensitivity (dB) assessed by MAIA microperimetry between macula-on (A) and macula-off (B) subgroups. Mean +/− standard deviation is included in every sector. Significant differences between the groups (p < 0.05) are presented in the gray background. MAIA: macular integrity assessment. RRD: rhegmatogenous retinal detachment; C global: central global.
Diagnostics 11 01157 g005
Figure 6. Retinal thickness measured by SS-OCT with the total retina protocol, GCL+ protocol and GCL++ protocol expressed in microns. Figure (A) represents macula-On subgroup and Figure (B) represents macula-Off. Mean +/− standard deviation is included in every sector. SS-OCT: swept source optical coherence tomography; ETDRS: Early Treatment Diabetic Retinopathy Study; GCL: Ganglion cell layer.
Figure 6. Retinal thickness measured by SS-OCT with the total retina protocol, GCL+ protocol and GCL++ protocol expressed in microns. Figure (A) represents macula-On subgroup and Figure (B) represents macula-Off. Mean +/− standard deviation is included in every sector. SS-OCT: swept source optical coherence tomography; ETDRS: Early Treatment Diabetic Retinopathy Study; GCL: Ganglion cell layer.
Diagnostics 11 01157 g006
Table 1. Clinical characteristics of both groups. Significant differences (p < 0.05) are highlighted in bold print.
Table 1. Clinical characteristics of both groups. Significant differences (p < 0.05) are highlighted in bold print.
VariableControl GroupRRD Groupp
Mean +/− SD
Median (Range)
Mean +/− SD
Median (Range)
Age (years)58.48 +/− 9.65
58 (33–83)
58.29 +/− 9.02
59 (33–72)
0.603
BCVA (logMAR)0.05 +/− 0.08
0.0 (0.0–0.5)
0.16 +/− 0.18
0.1 (0.0–0.6)
<0.001
SE (diopters)4.21 +/− 0.25
0.25 (−12.50–24.87)
−3.78 +/− 4.87
−1.75 (−14.00–1.50)
<0.001
AL (mm)24.38 +/− 2.95
23.63 (21.51–43.89)
26.12 +/− 3.59
25.4 (21.61–44.20)
<0.001
IOP (mmHg)13.59 +/− 2.64
14 (8–20)
14.42 +/− 2.26
15 (9–18)
0.056
Macular Integrity Index63.08 +/− 29.13
66.9 (2.9–100.00)
80.45 +/− 24.45
90.75 (6.20–100.0)
<0.001
Average Total Threshold (dB)26.44 +/− 2.68
27.1 (18.1–31.3)
24.28 +/− 4.33
25.4 (4.50–29.6)
<0.001
Fixation Stability P1 (%)82.50 +/− 18.35
88 (6–100)
79.34 +/− 26.91
91 (0–100)
0.578
Fixation Stability P2 (%)94.19 +/− 9.32
97 (27–100)
91.05 +/− 19.38
98 (1–100)
0.347
BCEA 63% area (degrees)2.80 +/− 3.86
1.6 (0.1–31.2)
4.52 +/− 10.70
1.45 (0.1–62.3)
0.383
BCEA 95% area (degrees)8.50 +/− 12.16
4.8 (0.2–93.4)
13.52 +/− 32.06
4.3 (0.4–186.7)
0.440
BCEA 63% angle (degrees)3.98 +/− 60.62
7 (−88.8–89.3)
−6.36 +/− 53.33
−6.9 (−86.7–84.6)
0.319
BCEA 95% angle (degrees)4.36 +/− 60.63
9 (−88.8–89.3)
−6.36 +/− 53.33
−6.9 (−86.7–84.6)
0.289
Fixation losses (%)5.94 +/− 13.33
0 (0–75)
3.82 +/− 10.49
0 (0–40)
0.942
RRD: rhegmatogenous retinal detachment; SD: standard deviation; BCVA: best-corrected visual acuity; SE: spherical equivalent; AL: axial length; IOP: intraocular pressure; BCEA: bivariate contour ellipse area.
Table 2. Spearman correlations between functional data measured by MAIA in different sectors and anatomic data measured by SS-OCT in the 4 sectors the inner ring according to the total retina protocol, GCL+ protocol and GCL++ protocol. Significant correlations (p < 0.05) are highlighted in bold print.
Table 2. Spearman correlations between functional data measured by MAIA in different sectors and anatomic data measured by SS-OCT in the 4 sectors the inner ring according to the total retina protocol, GCL+ protocol and GCL++ protocol. Significant correlations (p < 0.05) are highlighted in bold print.
ETDRS
SI
ETDRS
TI
ETDRS
II
ETDRS
NI
GCL+
SI
GCL+
TI
GCL+
II
GCL+
NI
GCL++
SI
GCL++
TI
GCL+
II
GCL++
NI
MP SOCorrelation coefficient−0.039−0.0320.019−0.0030.0410.0380.1160.1370.0120.0430.0650.046
p0.6340.6950.8120.9660.6210.6440.1570.0930.8840.6020.4300.576
MP TOCorrelation coefficient0.0670.0570.1200.0410.1160.0640.1970.1800.0450.0400.0920.072
p0.4170.4840.1410.6190.1540.4350.0150.0270.5840.6280.2630.378
MP IOCorrelation coefficient0.0190.0520.126−0.0100.1230.1180.1870.1320.0680.1060.0960.136
p0.8140.5270.1220.9080.1340.1500.0220.1060.4090.1960.2400.096
MP NOCorrelation coefficient−0.0160.0240.102−0.0320.0780.0660.1990.1560.0080.0670.1030.068
p0.8440.7700.2150.6940.3390.4220.0140.0550.9240.4110.2100.408
MP SICorrelation coefficient0.0630.0850.1040.0310.0710.0710.1700.1310.0260.0850.1120.021
p0.4420.2990.2050.7040.3870.3870.0370.1090.7530.2970.1710.796
MP TICorrelation coefficient0.0120.0340.044−0.0590.1080.0560.1620.0760.0340.0430.055−0.053
p0.8790.6820.5960.4720.1870.4930.0470.3560.6800.6010.5040.514
MP IICorrelation coefficient0.0620.0960.156−0.0030.1330.1020.1910.1290.0640.0820.0970.044
p0.4470.2420.0550.9720.1040.2140.0190.1150.4370.3200.2370.588
MP NICorrelation coefficient0.0080.0500.078−0.0280.0880.0860.1910.1570.0310.0780.0920.050
p0.9250.5380.3380.7330.2800.2910.0190.0550.7080.3420.2630.545
ETDRS: Early Treatment Diabetic Retinopathy Study; GCL: ganglion cell layer; MP: microperimetry; SO: superior outer; TO: temporal outer; IO: inferior outer; NO: nasal outer; SI: superior inner; TI: temporal inner; II: inferior inner; NI: nasal inner.
Table 3. Spearman correlations between functional data measured by MAIA and the clinical variables. Significant correlations (p < 0.05) are highlighted in bold print.
Table 3. Spearman correlations between functional data measured by MAIA and the clinical variables. Significant correlations (p < 0.05) are highlighted in bold print.
AgeBCVA (LogMAR)SEALIOP
MP SOCorrelation coefficient−0.191−0.3700.1360.0070.092
p0.019<0.0010.0950.9300.262
MP TOCorrelation coefficient−0.145−0.4160.228−0.121−0.132
p0.075<0.0010.0050.1400.106
MP IOCorrelation coefficient−0.122−0.3230.206−0.1400.009
p0.137<0.0010.0110.0860.912
MP NOCorrelation coefficient−0.129−0.3820.213−0.1200.053
p0.115<0.0010.0090.1430.519
MP SICorrelation coefficient−0.197−0.3850.159−0.113−0.004
p0.015<0.0010.0510.1660.964
MP TICorrelation coefficient−0.179−0.4250.238−0.167−0.061
p0.028<0.0010.0030.0400.460
MP IICorrelation coefficient−0.142−0.4330.254−0.211−0.024
p0.081<0.0010.0020.0090.773
MP NICorrelation coefficient−0.142−0.3910.241−0.1590.021
p0.081<0.0010.0030.0520.798
MP CCorrelation coefficient−0.192−0.3560.049−0.0430.012
p0.018<0.0010.5500.6000.885
MP CSCorrelation coefficient−0.128−0.3860.220−0.1910.000
p0.118<0.0010.0070.0190.996
MP CTCorrelation coefficient−0.140−0.4170.256−0.1680.052
p0.087<0.0010.0010.0390.529
MP CICorrelation coefficient−0.140−0.4610.294−0.1740.008
p0.087<0.001<0.0010.0320.925
MP CNCorrelation coefficient−0.105−0.3300.167−0.1570.006
p0.201<0.0010.0400.0540.942
MP C globalCorrelation coefficient−0.143−0.4340.251−0.2260.043
p0.079<0.0010.0020.0050.599
Macular Integrity IndexCorrelation coefficient0.1800.372−0.2200.1110.013
p0.027<0.0010.0070.1750.870
Average total ThresholdCorrelation coefficient−0.212−0.4390.249−0.159−0.009
p0.009<0.0010.0020.0510.913
BCVA: best-corrected visual acuity; SE: spherical equivalent; AL: axial length; IOP: intraocular pressure; MP: microperimetry; SO: superior outer; TO: temporal outer; IO: inferior outer; NO: nasal outer; SI: superior inner; TI: temporal inner; II: inferior inner; NI: nasal inner; C: central point; CS: superior central; CT: central temporal; CI: central inferior; CN: central nasal; C global: central global.
Table 4. Comparison for MAIA and clinical parameters between macula-on and -off subgroups. Significant differences (p < 0.05) are highlighted in bold print.
Table 4. Comparison for MAIA and clinical parameters between macula-on and -off subgroups. Significant differences (p < 0.05) are highlighted in bold print.
Macula-On RRDMacula-Off RRDp
Mean +/− SD
Median (Range)
Mean +/− SD
Median (Range)
Age (years)58.95 +/− 11.13
58.95 (33–71)
57.63 +/− 33
57.63 (44–72)
0.188
BCVA (logMAR)0.13 +/− 0.18
0.126 (0.0–0.6)
0.19 +/− 0.0
0.195 (0.0–0.6)
0.109
SE (diopters)−2.41 +/− 3.47
−2.41 (−14.00–1.25)
−5.14 +/− −14.00
−5.15 (−13.50–1.50)
0.313
AL (mm)26.84 +/− 4.55
26.84 (23.68–44.20)
25.39 +/− 23.68
25.39 (21.61–30.79)
0.293
IOP (mmHg)13.84 +/− 2.27
13.84 (9–17)
15.00 +/− 9
15 (10–18)
0.165
Days between surgery and study protocol472.95 +/− 449.9
472.95 (19–1458)
435.58 +/− 398.22
435.58 (26–1477)
0.965
Macular Integrity Index74.47 +/− 29.34
74.47 (6.2–100.0)
86.43 +/− 17.11
86.43 (54.8–100.0)
0.312
Average Total Threshold (dB)25.56 +/− 2,.78
25.56 (19.0–29.6)
22.99 +/− 5.23
22.99 (4.5–27.8)
0.041
Fixation Stability P1 (%)81.53 +/− 22.96
81.53 (21–100)
77.16 +/− 30.85
77.16 (0–100)
0.930
Fixation Stability P2 (%)94.11 +/− 10.50
94.11 (61–100)
88.00 +/− 25.34
88 (1–100)
0.761
BCEA 63% area (degrees)2.45 +/− 3.17
2.45 (0.2–11.3)
6.58 +/− 14.70
6.58 (0.1–62.3)
0.748
BCEA 95% area (degrees)7.32 +/− 9.51
7.32 (0.5–33.8)
19.73 +/− 44.07
19.73 (0.4–186.7)
0.759
BCEA 63% angle (degrees)−1.35 +/− 58.95
−1.35 (−86.7–84.6)
−11.37 +/− 48.15
−11.37 (−81.4–81.2)
0.589
BCEA 95% angle (degrees)−1.35 +/− 58.95
−1.35 (−86.7–84.6)
−11.37 +/− 48.15
−11.37 (−81,4–81.2)
0.589
Fixation losses (%)3.16 +/− 10.03
3.16 (0–40)
4.47 +/− 11.17
4.47 (0–40)
0.794
RRD: rhegmatogenous retinal detachment; SD: standard deviation; BCVA: best-corrected visual acuity; SE: spherical equivalent; AL: axial length; IOP: intraocular pressure; C global: central global.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Díaz-Barreda, M.D.; Bartolomé-Sesé, I.; Boned-Murillo, A.; Ferreras, A.; Orduna-Hospital, E.; Ascaso, F.J.; Pinilla, I. Microperimetry-Assessed Functional Alterations and OCT-Changes in Patients after Retinal Detachment Surgery Using Pars Plana Vitrectomy and SF6 Tamponade. Diagnostics 2021, 11, 1157. https://doi.org/10.3390/diagnostics11071157

AMA Style

Díaz-Barreda MD, Bartolomé-Sesé I, Boned-Murillo A, Ferreras A, Orduna-Hospital E, Ascaso FJ, Pinilla I. Microperimetry-Assessed Functional Alterations and OCT-Changes in Patients after Retinal Detachment Surgery Using Pars Plana Vitrectomy and SF6 Tamponade. Diagnostics. 2021; 11(7):1157. https://doi.org/10.3390/diagnostics11071157

Chicago/Turabian Style

Díaz-Barreda, María D., Isabel Bartolomé-Sesé, Ana Boned-Murillo, Antonio Ferreras, Elvira Orduna-Hospital, Francisco J. Ascaso, and Isabel Pinilla. 2021. "Microperimetry-Assessed Functional Alterations and OCT-Changes in Patients after Retinal Detachment Surgery Using Pars Plana Vitrectomy and SF6 Tamponade" Diagnostics 11, no. 7: 1157. https://doi.org/10.3390/diagnostics11071157

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop